FALOPPI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.520
EU - Europa 1.136
AS - Asia 859
SA - Sud America 299
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.894
Nazione #
US - Stati Uniti d'America 2.491
SG - Singapore 340
BR - Brasile 258
IT - Italia 207
UA - Ucraina 196
CN - Cina 171
SE - Svezia 130
DE - Germania 119
RU - Federazione Russa 113
IE - Irlanda 108
TR - Turchia 108
FI - Finlandia 79
DK - Danimarca 76
VN - Vietnam 73
HK - Hong Kong 55
GB - Regno Unito 47
KR - Corea 41
CI - Costa d'Avorio 34
FR - Francia 25
IN - India 21
MA - Marocco 21
JP - Giappone 17
MX - Messico 14
BD - Bangladesh 13
AR - Argentina 12
CA - Canada 11
EC - Ecuador 10
NL - Olanda 9
ES - Italia 8
ZA - Sudafrica 8
DZ - Algeria 7
ID - Indonesia 6
PL - Polonia 6
VE - Venezuela 6
CO - Colombia 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
EU - Europa 3
RS - Serbia 3
UY - Uruguay 3
BE - Belgio 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
PY - Paraguay 2
SA - Arabia Saudita 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
HN - Honduras 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
TN - Tunisia 1
Totale 4.894
Città #
Ashburn 287
Chandler 253
Singapore 223
Fairfield 219
Jacksonville 210
Wilmington 125
Dallas 118
Dublin 108
Boardman 100
Seattle 92
Woodbridge 89
New York 87
Centro 73
Houston 71
Cambridge 66
Ann Arbor 61
Hong Kong 55
Des Moines 53
Beijing 50
Los Angeles 49
Lawrence 44
Princeton 44
San Mateo 44
Turin 35
Abidjan 33
The Dalles 27
Ho Chi Minh City 25
Munich 24
Moscow 23
Helsinki 22
Turku 18
Hefei 17
Tokyo 17
London 16
San Diego 16
São Paulo 14
Hanoi 13
Rio de Janeiro 11
Atlanta 10
Buffalo 10
Chicago 10
Santa Clara 10
Pune 9
Stockholm 8
Wuxi 8
Brasília 7
Chennai 7
Columbus 7
Fortaleza 7
Izmir 7
Johannesburg 7
Orem 7
San Francisco 7
Belo Horizonte 6
Denver 6
Porto Alegre 6
Washington 6
Brooklyn 5
Frankfurt am Main 5
Guayaquil 5
Manchester 5
Montreal 5
Norwalk 5
Shanghai 5
St Petersburg 5
Warsaw 5
Bogotá 4
Cagliari 4
Curitiba 4
Fayetteville 4
Kilburn 4
Mexico City 4
Thái Nguyên 4
Wuhan 4
Amsterdam 3
Ancona 3
Ankara 3
Cairo 3
Campinas 3
Caxias do Sul 3
Dhaka 3
Duque de Caxias 3
Guangzhou 3
Milan 3
Montevideo 3
New Bedfont 3
Olomouc 3
Paris 3
Pittsburgh 3
Poplar 3
Portland 3
Prescot 3
Quito 3
Ribeirão Preto 3
Santo André 3
Sorocaba 3
Atibaia 2
Belgrade 2
Betim 2
Biên Hòa 2
Totale 3.128
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 177
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 174
Immunotherapy in genitourinary cancers: Where are we going? 171
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 168
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 167
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 143
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 138
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 137
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 135
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 130
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 130
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 128
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 126
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 123
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 120
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 119
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 118
Panitumumab for the treatment of metastatic colorectal cancer: A review 114
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 113
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 113
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 112
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 110
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 110
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 108
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 105
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 105
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 105
Trattamento del carcinoma del pancreas. Attualità e prospettive 104
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 102
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 96
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 96
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 95
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 95
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 94
Palliative treatment 93
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 91
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 87
Gastric cancer: Therapeutic choices in advanced disease 84
Cetuximab: still an option in the treatment of pancreatic cancer? Expert Opin Biol Ther. 2013 May;13(5):791-801 80
Selecting the best treatment for an individual patient. 79
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 78
Tracking the 2015 gastrointestinal cancers symposium: Bridging cancer biology to clinical gastrointestinal oncology 76
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 69
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 65
Totale 4.983
Categoria #
all - tutte 24.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 0 0 67 73 52 57 92 67 33
2021/2022357 28 82 7 6 2 23 15 24 20 54 26 70
2022/2023745 51 105 58 55 47 119 1 44 168 3 78 16
2023/2024388 59 4 39 50 60 104 6 4 1 6 7 48
2024/2025801 112 71 12 11 49 29 102 31 141 58 100 85
2025/20261.124 151 223 134 265 313 38 0 0 0 0 0 0
Totale 4.983